Symbol
Tarsus Pharmaceuticals, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$41.17
Current price of the stock
$569K
Trading volume of the stock
$1.6B
Market capitalization of the company
Small Cap
Category of market capitalization
50.76%
Long-term growth mean estimate
4.78
Mean analyst rating
69.42%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.30
Total debt to total equity ratio
5.42
Current ratio
93.26%
Gross profit margin
-52.29%
Operating profit margin
-52.29%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-48.67%
Pretax profit margin
-48.67%
Net profit margin
-9.86%
Measures profitability relative to shareholders' equity
-10.23%
ROE excluding intangible assets
-6.22%
Measures profitability relative to total assets
-7.57%
Measures profitability relative to invested capital
0.13
Asset turnover ratio
1.14
Inventory turnover ratio
1.59
Receivables turnover ratio
56.68
Average number of days it takes to collect receivables
-10.86
Measures valuation relative to earnings
-55.64
P/E based on future earnings estimates
12.19
Measures valuation relative to sales
6.62
Measures valuation relative to book value
-5.12
Measures valuation relative to operating cash flow
-5.04
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
